Navigation Links
First Study To Show Positive Benefit On Atherosclerosis For People,With Early Signs Of Diseased Arteries

hieved their LDL-C goal utilizing the 20mg dose of CRESTOR.

-Ends-
25 March 2007

Media enquiries:
Edel McCaffrey, Tel: +44 (0) 207 304 5034
Steve Brown, Tel: +44 (0) 207 304 5033

Investor Relations:
Mina Blair, Tel: +44 (0) 207 304 5084
Jonathan Hunt, Tel: +44 (0) 207 304 5087
Jörgen Winroth, Tel: +1 (212) 579 0506
Ed Seage, Tel: +1 302 886 4065

Notes To Editors
* People at low-risk of coronary heart disease as described in the METEOR study had a Framingham 10- year risk of less than 10 percent. The Framingham risk score is a method to determine an individual's risk of having either a fatal or non-fatal heart attack over the following 10 years. The risk score is based on an
individual's cholesterol level, blood pressure, smoking status, age and gender.

ASTEROID (A Study To Evaluate the Effect of Rosuvastatin On Intravascular Ultrasound-Derived Coronary Atheroma Burden) was a 104-week, open label, single-arm, blinded endpoint study designed to study the effect of CRESTOR 40mg in 507 patients who had undergone coronary angiography and who had evidence of coronary artery disease (CAD).
Key findings from ASTEROID include:

CRESTOR brought about a 0.79 per cent (median) reduction in percent atheroma volume in the entire target vessel (p<0.001) – first primary endpoint
CRESTOR brought about a 9.1 per cent (median) reduction in total atheroma volume in the most diseased 10mm segment of the target vessel (p<0.001) – second primary endpoint
CRESTOR brought about a 6.8 per cent (median) reduction in total atheroma volume in the entire target vessel (p<0.001) – secondary endpoint
These changes were associated with a 53 per cent reduction in LDL-C (p<0.001) and a 15% increase in HDL-C (p<0.001)
ORION (Outcome of Rosuvastatin Treatment on Carotid Artery Atheroma: a Magnetic Resonance Imaging ObservatioN) was the first study to
'"/>




Page: 1 2 3 4 5

Related medicine technology :

1. Data Available From Erbitux Phase III Study in First-Line Treatment of Advanced Lung Cancer
2. Pixantrone Combination Therapy for First-line Treatment of Aggressive Non-Hodgkins Lymphoma Results in Reduction in Severe Toxicities Including Heart Damage When Compared to Doxorubicin-based Therapy
3. Genzyme Announces Data from First Phase 3 Study of Tolevamer in Patients with C. difficile Associated Diarrhea
4. Ablynx Announces Interim Results of First Nanobody Phase I Study of ALX-0081 (ANTI-VWF)
5. Advanced Life Sciences Announces Supplemental Efficacy Data from First Pivotal Phase 3 Pneumonia Clinical Trial
6. Advanced Life Sciences to Host Conference Call to Discuss Data From Cethromycins First of Two Phase 3 Pneumonia Trials
7. First Phase II Short-Term Study on Dapagliflozin Shows Results on Safety, Tolerability and Glycemic Markers in Subjects With Type 2 Diabetes
8. Advanced Cell Technology Develops First Human Embryonic Stem Cell Line without Destroying an Embryo
9. First Demonstration of nanoImmunology: a Nanomaterials-based Therapeutic Approach to Treat Allergy
10. First single breast cancer study to show significant survival benefit for women switching from tamoxifen to Arimidex
11. Mymetics HIV Vaccine Demonstrates First-Ever Production of Neutralizing IgA Antibodies in Non-Human Primate Model
Post Your Comments:
(Date:9/19/2014)... , Sept. 19, 2014  CytRx Corporation (Nasdaq: ... company specializing in oncology, today announced that David ... at BioCentury,s 2014 NewsMakers in the Biotech Industry Conference on ... Time. The conference will take place at the Millennium ... . A live and archived webcast of ...
(Date:9/18/2014)... 18, 2014  Low T Center endorses the ... Hyattsville, Maryland earlier this ... proper patient population for testosterone therapy (TRT), as ... with TRT. Examining recent claims from studies that TRT ... epidemiological studies do not provide convincing evidence that ...
(Date:9/18/2014)... , Sept. 18, 2014   MacPractice,s MacPractice ... Edition Complete EHR certification, which designates that the software ... Stage 1 and Stage 2 Meaningful Use measures required ... Reinvestment Act (ARRA).  MacPractice MD MU version 5.0 was ... , an Office of the National Coordinator-Authorized Certification Body ...
Breaking Medicine Technology:CytRx to Present at BioCentury's 2014 NewsMakers in the Biotech Industry Conference 2CytRx to Present at BioCentury's 2014 NewsMakers in the Biotech Industry Conference 3Low T Center Endorses The Joint FDA Committee Meeting on Testosterone 2MacPractice MD MU Achieves ONC HIT 2014 Edition Complete EHR Certification from ICSA Labs 2MacPractice MD MU Achieves ONC HIT 2014 Edition Complete EHR Certification from ICSA Labs 3MacPractice MD MU Achieves ONC HIT 2014 Edition Complete EHR Certification from ICSA Labs 4MacPractice MD MU Achieves ONC HIT 2014 Edition Complete EHR Certification from ICSA Labs 5
... 2011 Heska Corporation (NASDAQ: ... veterinary diagnostic and other specialty veterinary products , today ... best practices research, tools and metrics for patent analysis ... Heska,s Science Strength in the top 50 of the ...
... released by SCM: (Photo:   http://photos.prnewswire.com/prnh/20111006/LA81891 ) ... of closing statements, lead trial attorney for the plaintiffs in ... asked jurors to bring a verdict of $10 million in ... for James Arnold and to consider whether the Arnolds should ...
Cached Medicine Technology:The Patent Board, IP Tracking and Analysis Firm, Ranks Heska's Science Strength in Biotechnology Industry Top 50 2Lead Trial Attorney in Clark County Hepatitis C Trial, Robert Eglet, Asks Jury to Award $10 Million Compensatory Damages for Anne Arnold, $2.5 Million for James Arnold 2
(Date:9/19/2014)... 2014 United Benefit Advisors (UBA), ... its annual Fall Meeting & Expo at the ... Illinois. With a fantastic attendance of more ... new CEO, Les McPhearson, led these thought leaders ... what is required of successful advisor firms looking ...
(Date:9/19/2014)... September 19, 2014 Script Relief, ... on all commonly prescribed high blood pressure medications. ... drug coupons and has saved its users over ... of making prescription medications more accessible and affordable, ... blood pressure medications. , High blood pressure, also ...
(Date:9/19/2014)... Indiana Fiber Network, LLC (IFN), the leading Indiana ... Fiber Transport Services, adding Point of Presence (PoP) at ... PoP at Cermak, IFN enables interconnect opportunities for Carriers, ... fiber transport service to US and Global Carriers. ... Sales and Marketing August Zehner, establishing a PoP at ...
(Date:9/19/2014)... AttorneyOne.com, a recognized authority on law, update the website ... Potassium Chloride . , The FDA announced on ... lot of Potassium Chloride Injection 10mEq per 100mL due to ... intravenously, is used to treat potassium deficiency. , The ... on the shipping cartons in a single lot where, for ...
(Date:9/19/2014)... A McLean County woman filed ... following a failed hip replacement using a DePuy XL ... Inc. and Johnson & Johnson over allegations that they ... nationally known personal injury law firm, represents defective hip ... involving defective hips. , According to the lawsuit, Owens ...
Breaking Medicine News(10 mins):Health News:United Benefit Advisors New CEO Presides Over Fall Meeting & Expo 2Health News:United Benefit Advisors New CEO Presides Over Fall Meeting & Expo 3Health News:HelpRx.info Now Providing Discounts on All Common High Blood Pressure Medications 2Health News:HelpRx.info Now Providing Discounts on All Common High Blood Pressure Medications 3Health News:Indiana Fiber Network Launches Point-Of-Presence in Chicago Data Center at Cermak 2Health News:Baxter Recalls Potassium Chloride Injection: AttorneyOne Monitors and Keeps Consumers Informed 2Health News:Flood Law Group Comments on Recent Hip Replacement Lawsuit 2
... ... Fresh, Nutritious, and Creative , ... Santa Cruz, CA (Vocus) June 18, 2010 -- School’s about to start and so ... J? Switch it up with kids’ bento boxes , from Laptop Lunches. ...
... ... people of all faiths in Dallas, TX, on June 27th and 28th, 2010. Spiritual ... her love and compassion in person. , ... Dallas, TX (PRWEB) June 18, 2010 -- The ‘Hugging Saint’ Amma ( http://www.amma.org ...
... ... their new 360 Degree Guarantee and provide consumers with coverage that extends past the original ... by a standard warranty. , ... (PRWEB) June 18, 2010 -- Treadmill Doctor has announced the introduction of their ...
... ... barometer for hiring this fall, we are about to see a significant pickup in recruiting from ... (PRWEB) June 18, 2010 -- ... leading indicator for future hiring activity. “It only makes sense, says RD Whitney, CEO of Onrec ...
... ... industry lived up to its tagline - “Connecting you to good health” when it successfully ... , ... Makewell Meditour Ltd., a pioneer in India’s medical tourism industry lived up to ...
... trial of a new model for testing Alzheimer,s treatments has ... exacerbate the disease if treatment is interrupted. Scientists at ... & Co. Inc studied the effects of a class of ... these drugs might cause a build-up of proteins linked to ...
Cached Medicine News:Health News:Kids' Lunchboxes Go Bento for Easy Back to School Lunch Making, Thanks to Laptop Lunches 2Health News:The &#8216;Hugging Saint' Amma Visits Dallas June 27-28, 2010, Offering Spiritual Upliftment to People of All Faiths 2Health News:Treadmill Doctor 360 Degree Guarantee Extended Service Plans 2Health News:Onrec Predicts Significant Recruiting Activity this Fall 2Health News:Onrec Predicts Significant Recruiting Activity this Fall 3Health News:Onrec Predicts Significant Recruiting Activity this Fall 4Health News:Makewell Meditour Helps Nigerian Family Find a Facility to Perform Rare Separation Surgery for Conjoined Twins 2Health News:Makewell Meditour Helps Nigerian Family Find a Facility to Perform Rare Separation Surgery for Conjoined Twins 3Health News:New model suggests feared side effect of Alzheimer's drugs is unlikely 2
Upon application to intact skin, Skin-Prep* protective wipes forms a protective film that prepares the skin for the attachment of drainage tubes, external catheters, adhesive dressings and can be...
Triad Plus Sterile Isopropyl Alcohol 70% USP Prep Pads are medium size. Each package is terminally sterilized, ensuring the safest possible product....
Aplicare's Prep Pads offer convenience, low cost, ease of use. The medium size is appropriate for most applications. Each package is terminally sterilized, ensuring the safest possible product for th...
... Triad Plus Sterile ... Swabsticks are primarily used ... prior to administering injections. ... to meet AAMI/ANSI/ISO 11137 ...
Medicine Products: